Diversity as a Strategic Priority

How can your I&D goals thrive? Walk the talk, says Florida Blue's CEO.

President and CEO, Florida Blue
CEO, Health Evolution
Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman

Even for those who work in healthcare, finding a good doctor's hard. Measures of physician appropriateness will transform care delivery.

Principal, Oliver Wyman
Global Head, Health Services, Oliver Wyman
Engagement Manager, Health & Life Sciences, Oliver Wyman

Four ways AI is a powerful diagnostic and therapeutic tool to help people with mental illness.

Partner, Health & Life Sciences, Oliver Wyman
Partner, Health & Life Sciences, Oliver Wyman

Predictions on the next wave of innovation, what consumers really want, and how it's all impacting employer benefits.

Q&A with the Academy of Nutrition and Dietetics on malnutrition's greatest challenges and opportunities

What if your doctor handed out grocery lists, not a grocery list of pills to take?

Principal, Oliver Wyman
Chief Science Officer, Academy of Nutrition and Dietetics

Insights in your inbox

Subscribe

Here’s how organizations like Zipongo, ProMedica, and Walmart are strategizing around the food as medicine movement.

Partner, Health & Life Sciences, Oliver Wyman
Vice President, Health Transformation, Walmart
President & CEO, ProMedica
Founder and CEO

Hospital systems seek sustainability, scale, and relevance. Models that rethink tradition will thrive.

Partner, Health & Life Sciences, Oliver Wyman
Principal, Health & Life Sciences, Oliver Wyman

2018 was a big year for industry news. Here's what might happen next in artificial intelligence, the 2020 presidential election, pharma, and more.

Partner, Health & Life Sciences, Oliver Wyman
Managing Partner, Health & Life Sciences, and Global Chair for I&D, Oliver Wyman

Despite its unstable global geopolitical climate, Asia is primed for steady change this year in healthcare.

Principal, Health & Life Sciences, Oliver Wyman
Partner, Head of Health & Life Sciences, Asia Pacific, Oliver Wyman

Some of our 2018 predictions on consolidation, pharma, and investment came true, while others were less predictable.

Principal, Oliver Wyman

Insights in your inbox

Subscribe
Load More